Exponent (NASDAQ:EXPO) Releases Earnings Results

Exponent (NASDAQ:EXPOGet Free Report) issued its earnings results on Thursday. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.07, Briefing.com reports. Exponent had a return on equity of 29.01% and a net margin of 19.35%. The business had revenue of $132.43 million during the quarter, compared to the consensus estimate of $130.83 million. During the same period last year, the company earned $0.50 EPS. The company’s revenue for the quarter was up 2.1% on a year-over-year basis.

Exponent Price Performance

Shares of NASDAQ:EXPO traded down $0.62 during midday trading on Friday, reaching $105.45. 359,737 shares of the company’s stock were exchanged, compared to its average volume of 190,804. The firm’s 50 day simple moving average is $97.16 and its two-hundred day simple moving average is $88.42. The stock has a market cap of $5.35 billion, a price-to-earnings ratio of 53.26 and a beta of 0.65. Exponent has a fifty-two week low of $64.61 and a fifty-two week high of $108.00.

Exponent Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Investors of record on Friday, September 6th will be given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date of this dividend is Friday, September 6th. Exponent’s payout ratio is 56.57%.

Wall Street Analysts Forecast Growth

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research note on Friday.

Read Our Latest Research Report on EXPO

Insider Buying and Selling

In related news, insider Eric Guyer sold 1,650 shares of the firm’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total transaction of $152,757.00. Following the completion of the transaction, the insider now directly owns 1,846 shares in the company, valued at approximately $170,902.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Eric Guyer sold 1,650 shares of Exponent stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $92.58, for a total value of $152,757.00. Following the completion of the transaction, the insider now owns 1,846 shares in the company, valued at approximately $170,902.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul R. Johnston sold 6,000 shares of Exponent stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $95.11, for a total value of $570,660.00. Following the completion of the transaction, the director now owns 79,236 shares of the company’s stock, valued at approximately $7,536,135.96. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,067 shares of company stock valued at $4,734,995. 2.10% of the stock is currently owned by insiders.

Exponent Company Profile

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Earnings History for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.